advertisement

Topcon

Abstract #19364 Published in IGR 9-3

Role of MYOC and OPTN sequence variations in Spanish patients with primary open-angle glaucoma

Lopez-Martinez F; Lopez-Garrido M-P; Sanchez-Sanchez F; Campos-Mollo E; Coca-Prados M; Escribano J
Molecular Vision 2007; 13: 862-872


PURPOSE: To retrospectively investigate the contribution of myocilin (MYOC) and optineurin (OPTN) sequence variations to adult-onset ocular hypertension (OHT) and primary open-angle glaucoma (POAG) in Spanish patients. METHODS: The promoter region and the three exons of MYOC were analyzed by direct PCR DNA sequencing in 40 OHT and 110 POAG unrelated patients. We used 98 subjects in whom OHT or glaucoma had been ruled out as controls. We also screened the complete coding region of the OPTN gene (exons 4-16) in all subjects by single-stranded conformational polymorphisms (SSCPs). RESULTS: We identified six common single nucleotide polymorphisms (SNPs) in the promoter region of MYOC (-1000C>G, -387C>T, -306G>A, -224T>C, -126T>C and -83G>A) and a polymorphic GT microsatellite (-339(GT)11-19). In addition, we detected four novel, rare DNA polymorphisms. None of these DNA sequence variations were associated with either OHT or POAG. We also found three (2.7%) POAG patients with MYOC pathogenic mutations. Two of these pathogenic mutations (GIn368Stop and Ala445Val) were previously described whereas the third (Tyr479His) was novel. Transient expression of the novel mutation in 293T cells supported its pathogenicity. Only two OPTN polymorphisms, which are not associated with the disease, were detected. CONCLUSIONS: Overall, our data show that in Spain a minority of adult-onset high-pressure POAG patients carry heterozygous disease-causing mutations in the MYOC gene and that OPTN is not involved in either OHT or POAG.

Dr. J. Escribano, Area de Genetica, Facultad de Medicina, Avda. de Almansa 14, 02006 Albacete, Spain. julio.escribano@uclm.es


Classification:

3.4.1 Linkage studies (Part of: 3 Laboratory methods > 3.4 Molecular genetics)



Issue 9-3

Change Issue


advertisement

Oculus